As layoffs rise, new data highlights AI-resilient careers in health care and skilled trades, with Oklahoma training programs meeting growing demand.

NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), a clinical stage leader developing revolutionary broad-spectrum antiviral drugs that the virus cannot escape, announced that it will be ...

Research and development expense in fiscal Q3 2025 -- $4.5 million versus $4.9 million in fiscal Q3 2024. Net loss -- $5.9 ...

Inovio Pharmaceuticals (INO) reported a disappointing 3Q25 with a GAAP EPS loss of -$0.87, missing consensus by $0.45 and ...

However, just one or a few mutations would be required in the currently circulating H5N1 bird flu viruses to become efficient in human-to-human transmission. Two different clades of H5N1 are ...

Phase 2a data support oral C5aR inhibitor INF904 as a potentially transformational and best-in-class immunomodulatory agent, indicating strong ...

For more than two decades, Bracco has made education a cornerstone of progress in radiology. In 2024 alone, Bracco's educational programs reached over 100,000 healthcare professionals worldwide, ...

A mother and her daughter with a rare disease in Guangzhou, South China's Guangdong Province, on January 31, 2024 Photo: VCG.

Q3 2025 Earnings Call Transcript October 28, 2025 Regeneron Pharmaceuticals, Inc. beats earnings expectations. Reported EPS is $11.83, expectations were $9.65. Operator: Welcome to the Regeneron ...

MoneyWeek's experts tell us what they would go for if they could pick only one stock, sector or market for the next quarter-century. Tips range from defence and agriculture to Vietnam and Jardine Math ...

Allergan Aesthetics, an AbbVie company , today announced it will present data highlighting efficacy, safety and patient-reported outcomes across its portfolio during the 2025 American Society of ...